Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical sepsis phenotypes in critically ill COVID-19 patients.
Bruse N, Kooistra EJ, Jansen A, van Amstel RBE, de Keizer NF, Kennedy JN, Seymour C, van Vught LA, Pickkers P, Kox M. Bruse N, et al. Among authors: van vught la, van amstel rbe. Crit Care. 2022 Aug 9;26(1):244. doi: 10.1186/s13054-022-04118-6. Crit Care. 2022. PMID: 35945618 Free PMC article.
Mortality associated with early changes in ARDS severity in COVID-19 patients - Insights from the PRoVENT-COVID study.
Schuijt MTU, Martin-Loeches I, Schultz MJ, Paulus F, Neto AS; PRoVENT-COVID; PRoVENT-COVID Collaborative Group members. Electronic address: provent-covid@amsterdamumc.nl; PRoVENT-COVID Collaborative Group members. Schuijt MTU, et al. J Crit Care. 2021 Oct;65:237-245. doi: 10.1016/j.jcrc.2021.06.016. Epub 2021 Jul 7. J Crit Care. 2021. PMID: 34271294 Free PMC article.
Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients - insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysis.
Ahuja S, de Grooth HJ, Paulus F, van der Ven FL, Serpa Neto A, Schultz MJ, Tuinman PR; PRoVENT-COVID Study Collaborative Group* ‘PRactice of VENTilation in COVID–19’. Ahuja S, et al. Crit Care. 2022 Jun 1;26(1):157. doi: 10.1186/s13054-022-04023-y. Crit Care. 2022. PMID: 35650616 Free PMC article.
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Vlaar APJ, Witzenrath M, van Paassen P, Heunks LMA, Mourvillier B, de Bruin S, Lim EHT, Brouwer MC, Tuinman PR, Saraiva JFK, Marx G, Lobo SM, Boldo R, Simon-Campos JA, Cornet AD, Grebenyuk A, Engelbrecht JM, Mukansi M, Jorens PG, Zerbib R, Rückinger S, Pilz K, Guo R, van de Beek D, Riedemann NC; PANAMO study group. Vlaar APJ, et al. Lancet Respir Med. 2022 Dec;10(12):1137-1146. doi: 10.1016/S2213-2600(22)00297-1. Epub 2022 Sep 7. Lancet Respir Med. 2022. PMID: 36087611 Free PMC article. Clinical Trial.
Integrating biology into clinical trial design.
van Amstel RBE, van Vught LA, Bos LDJ. van Amstel RBE, et al. Curr Opin Crit Care. 2023 Feb 1;29(1):26-33. doi: 10.1097/MCC.0000000000001007. Epub 2022 Dec 9. Curr Opin Crit Care. 2023. PMID: 36580371 Review.
Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a and antidrug antibodies in PANAMO: a phase 3 study in critically ill,  invasively mechanically ventilated COVID-19 patients.
Lim EHT, Vlaar APJ, de Bruin S, Rückinger S, Thielert C, Habel M, Guo R, Burnett BP, Dickinson J, Brouwer MC, Riedemann NC, van de Beek D; PANAMO study group. Lim EHT, et al. Intensive Care Med Exp. 2023 Jun 19;11(1):37. doi: 10.1186/s40635-023-00520-8. Intensive Care Med Exp. 2023. PMID: 37332066 Free PMC article.
27 results